 |
Novel more efficient therapeutic approaches against Crohn's disease |
| |
Using a unique murine model for human Crohn's disease, MUGEN's NoE participants [G. Kollias, D. Kontoyiannis (Fleming), W. Mόller (HZI), B. Malissen (CNRS]) identified key molecules that control T lymphocyte migration to the small intestine. Their discovery brings into focus the use of novel, more efficient therapeutic approaches against Crohn's disease. |
more info
|
|
|
 |
2nd MUGEN Phenotyping Technological Workshop |
| |
The MUGEN management office would like to announce the first call for the 2nd MUGEN Phenotyping Technological Workshop. The workshop will take place at Manchester University on the 16th and 17th of June 2008 at the University of Manchester. |
more info
|
|
|
 |
The future of gene therapy compromised? |
| |
Lausanne, 12 March 2008. MUGEN participant Professor Jurg Tschopp and his colleagues have reported that activation of the inflammasome, a multi-protein complex involved in the innate immune response against many pathogens, is also important for the generation of an effective inflammatory response to adenoviruses and other DNA viruses. |
more info
|
|